Patents by Inventor James Matson

James Matson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitumor antibiotic compound
    Patent number: 4582639
    Abstract: A new cyclic depsipeptide antitumor antibiotic designated herein as sandramycin is produced by fermentation of a new microorganism, Nocardioides sp. strain C49,009, ATCC 39419. Sandramycin possesses antibacterial activity and inhibits the growth of tumors in experimental animals.
    Type: Grant
    Filed: June 18, 1984
    Date of Patent: April 15, 1986
    Assignee: Bristol-Myers Company
    Inventors: James A. Matson, James A. Bush
  • Process for preparing 4'-deschlororebeccamycin
    Patent number: 4567143
    Abstract: A new antitumor antibiotic designated herein as 4'-deschlororebeccamycin is produced by fermentation of Nocardia aerocolonigenes ATCC 39243. The new compound possesses antibacterial activity and inhibits the growth of tumors in experimental animals.
    Type: Grant
    Filed: March 18, 1985
    Date of Patent: January 28, 1986
    Assignee: Bristol-Myers Company
    Inventor: James A. Matson
  • 4'-Deschlororebeccamycin pharmaceutical composition and method of use
    Patent number: 4524145
    Abstract: A new antitumor antibiotic designated herein as 4'-deschlororebeccamycin is produced by fermentation of Nocardia aerocolonigenes ATCC 39243. The new compound possesses antibacterial activity and inhibits the growth of tumors in experimental animals.
    Type: Grant
    Filed: September 4, 1984
    Date of Patent: June 18, 1985
    Assignee: Bristol-Myers Company
    Inventor: James A. Matson
  • Antitumor agents albacarcins V and M
    Patent number: 4461831
    Abstract: Novel antitumor antibiotics designated herein as albacarcins M and V are produced by fermentation of Streptomyces albaduncas strain C-38291 (ATCC 39151). The new antibiotics possess antibacterial activity and also inhibit the growth of mammalian tumors such as P388 leukemia in mice.
    Type: Grant
    Filed: August 16, 1982
    Date of Patent: July 24, 1984
    Assignee: Bristol-Myers Company
    Inventors: James A. Matson, Robert W. Myllymaki, Terrence W. Doyle, James A. Bush